Pivotal Study in Advanced Parkinsons Disease Patients (Q65383490)
Jump to navigation
Jump to search
clinical trial
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Pivotal Study in Advanced Parkinsons Disease Patients |
clinical trial |
Statements
A Double-blind, Double-dummy, Placebo-controlled, Randomized, Three Parallel Groups Study Comparing the Efficacy, Safety and Tolerability of Pramipexole Extended Release (ER) Versus Placebo and Versus Pramipexole Immediate Release (IR) Administered Orally Over a 26-week Maintenance Phase in L-Dopa+ Treated Patients With Advanced Parkinsons Disease (PD). (English)
0 references
April 2007
0 references
November 2008
0 references
517
0 references
32 year
0 references